University of Colorado, Boulder
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Colorado, Boulder sits in the top decile of US sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count).
University of Colorado, Boulder: 69 sponsored US clinical trials, 15 recruiting.
University of Colorado, Boulder sponsors 69 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 48 completed. 3 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Aging, with 4 trials.
Top-decile sponsor footprint
University of Colorado, Boulder ranks in the top decile of sponsors by registered trial count (#307 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
48 of 49 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (98.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
69 total, page 1 of 2
The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
NCT07636200
Exercise Adherence and Cognitive Decline: Phase 2
NCT07127965
Perceptual Influences From Smoking Cannabis: an Experimental Study
NCT06588582
Studies of Human Inference Using On-line Testing
NCT05848752
Exercise Adherence and Cognitive Decline
NCT06769022
Cannabis for Palliative Care in Cancer
NCT06266611
Adipocyte-Derived Extracellular Vesicles, Weight Loss, and Endothelial Function
NCT06776081
Group Exposure Workshops for Socially Anxious Undergraduates
NCT06673407
Longitudinal Outpatient Treatment for Cannabis Use Disorder
NCT06107062
Cannabidiol and Older Adult Cannabis Users
NCT06290063
Pathophysiology of Circadian Rhythm Delayed Sleep Wake Phase Disorder
NCT06471374
Biomarkers for Peripheral Circadian Clocks in Humans
NCT06296823
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
NCT05500963
Passive Heat Therapy for Lowering Systolic Blood Pressure and Improving Vascular Function in Mid-life and Older Adults
NCT05300971
Inspiratory Muscle Strength Training for Lowering Blood Pressure and Improving Endothelial Function in Postmenopausal Women: Comparison With "Standard of Care" Aerobic Exercise
NCT05000515
Fisetin to Improve Vascular Function in Older Adults
NCT06133634
Mitochondrial-targeted Antioxidant Supplementation for Improving Age-related Vascular Dysfunction in Humans
NCT04851288
Nitrite-boosting Therapy for Improving Physiological Function in Patients With Chronic Kidney Disease
NCT03826147
Human Neural Correlates of Multi-Timescale Inference
NCT07606469
Neural Substrates Underlying Adaptations in Manual Dexterity of Older Adults
NCT07011160
WRITE: Written Imaginal Thinking Exercise Study
NCT07464158
Smartphone App-guided Inspiratory Muscle Strength Training for Lowering Systolic Blood Pressure
NCT06229873
The Effects of Probiotic Supplementation on State and Trait Stress, Anxiety, and Depression Symptoms in Stressed Adults
NCT07216729
Light Therapy for Obsessive-compulsive Disorder (OCD)
NCT05391503
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 1
NCT05868213
The Effect of Acute Intermittent Hypoxia on Motor Learning
NCT05341466
Trial of Written Exposure for Metastatic Cancer Patients (EASE)
NCT06042400
Aging and Marijuana: Benefits, Effects, and Risks
NCT05188404
Randomized Clinical Trial of a Multi-Modal Palliative Care Intervention
NCT04773639
The Peer-Delivered "Mind. Body. Voice." Program for High School Women (Mbv) - Remote
NCT04591912
Exploring the Anti-inflammatory Properties of Cannabis and Their Relevance to Insulin Sensitivity
NCT04114903
The Peer-Delivered "Mind. Body. Voice." Program for High School Women
NCT04591886
Environmental Health Effects on Your Physiology
NCT03986814
The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
NCT03980093
Randomized Controlled Trial of the Alma Peer Mentoring Program for Pregnant Women Experiencing Depression
NCT02883686
How Does Mindful Mood Balance for Moms Work?
NCT05000879
The Peer-Delivered Body Project for Young Women in High School
NCT04263155
Pain Research: Innovative Strategies With Marijuana
NCT03522324
Anxiety, Inflammation, Stress, and Cannabinoids
NCT03491384
Understanding Mechanisms of Exercise Behavior Change
NCT03465800
Strategies to Enhance the Experience of Exercise
NCT03453671
Mind-body Treatments for Chronic Back Pain
NCT03294148
Understanding Mechanisms of Health Behavior Change
NCT03192254
Effects of Intranasal Oxytocin Administration on Social Influence Effects on Pain
NCT03060031
Biomarkers of Insufficient Sleep and Sleepiness
NCT03130803
Sleep, Blood Pressure and Vascular Health
NCT04017039
Health Effects of Increasing Muscle Activation While Sitting in Office Workers
NCT02855541
Denver Garden Environment and Microbiome Study Disease
NCT03089151
Treatment Seeking for Social Anxiety
NCT04196296
HIV-1, Insufficient Sleep and Vascular Endothelial Dysfunction
NCT04956861
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 4 |
| Phase 4 | 3 |
Therapeutic Areas
What is open in the University of Colorado, Boulder pipeline
15 recruiting of 69 indexed (22% open); 48 completed (70%).
Phase mix: 3 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Aging (4 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Colorado, Boulder: open-pipeline peers nationwide
Peers matched on 69 registered trials and 22% open enrollment, not the therapeutic-area sidebar.
University of Colorado, Boulder sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 69 trials (± recruiting share)
- Mallinckrodt · 69 trials · 0% recruiting
- Providence Health & Services · 69 trials · 7% recruiting
- Texas Tech University · 69 trials · 17% recruiting
- Procter and Gamble · 70 trials · 0% recruiting
Sponsors near 22% open enrollment (± trial volume)
- AtriCure · 22% recruiting · 23 trials
- University of Maryland, College Park · 22% recruiting · 46 trials
- Regeneron Pharmaceuticals · 22% recruiting · 280 trials
- Henry M. Jackson Foundation for the Advancement of Military Medicine · 22% recruiting · 60 trials
Related
What to do with this University of Colorado, Boulder page
69 registered trials is a research-attention snapshot, not an endorsement of University of Colorado, Boulder or any single study.
- 15 of University of Colorado, Boulder's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Aging is the condition University of Colorado, Boulder studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Aging trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Colorado, Boulder pipeline card: 69 registered trials from official public datasets.Report a data error.